Polymeric micellar paclitaxel plus cisplatin combined with tislelizumab as the first-line treatment of advanced unresectable esophageal squamous cell carcinoma: A phase II study.

被引：0
|
作者：
Cao, Guochun
Li, Xiaoyou
Liu, Delin
Zhu, Jinghua
机构：
[1] Nanjing Med Univ, Affiliated Canc Hosp, Dept Clin Oncol, Jiangsu Canc Hosp,Jiangsu Inst Canc Res, Nanjing, Peoples R China
[2] Jiangsu Canc Hosp, Dept Med Oncol, Nanjing, Peoples R China
[3] China Jinagsu Prov Inst Canc Res, Nanjing, Jiangsu, Peoples R China
[4] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16022
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tislelizumab plus chemotherapy as first-line treatment for unresectable, locally advanced recurrent/metastatic esophageal squamous cell carcinoma
    Yoon, Harry H.
    Kato, Ken
    Hubner, Richard
    Raymond, Eric
    Tao, Aiyang
    Liu, Sumei
    Qazi, Ibrahim
    Xu, Jian-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [2] Tislelizumab Plus Chemotherapy as First-line Treatment for Advanced Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma
    Xu, Jianming
    Bai, Yuxian
    Xu, Nong
    Li, Enxiao
    Wang, Buhai
    Wang, Jin
    Li, Xiang
    Wang, Xin
    Yuan, Xianglin
    CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4542 - 4550
  • [3] Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    Fang, Rui
    Wang, Suiqiong
    Liu, Yongqian
    Xu, Jun
    ADVANCES IN THERAPY, 2023, 40 (03) : 1019 - 1030
  • [4] A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma
    Wang, Hai-ying
    Yao, Zhi-hua
    Tang, Hong
    Zhao, Yan
    Jin, Shui-ling
    Zhou, Wen-ping
    Yao, Shu-na
    Yang, Shu-jun
    Liu, Yan-yan
    Luo, Su-xia
    ONCOTARGET, 2017, 8 (05) : 7540 - 7547
  • [5] Efficacy and safety of KN046 plus paclitaxel/cisplatin as first-line treatment for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC).
    Xu, Jianming
    Liu, Rongrui
    Zhang, Yanqiao
    Xu, Nong
    Fan, Qingxia
    Gao, Shegan
    Pan, Hongming
    Cai, Mingquan
    Yan, Dong
    Liang, Qianqian
    Wu, Qiong
    Guo, Baohong
    Qi, Yakun
    Xu, Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    Rui Fang
    Suiqiong Wang
    Yongqian Liu
    Jun Xu
    Advances in Therapy, 2023, 40 : 1019 - 1030
  • [7] HEALTH OUTCOME IN PATIENTS WITH ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA TREATED WITH FIRST-LINE SINTILIMAB PLUS CISPLATIN AND PACLITAXEL VERSUS CISPLATIN AND PACLITAXEL
    Sun, L.
    VALUE IN HEALTH, 2022, 25 (12) : S53 - S53
  • [8] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
    Lee, Jeeyun
    Im, Young-Hyuck
    Cho, Eun Yoon
    Hong, Yong Sang
    Lee, Hyo Rak
    Kim, Hyo Song
    Kim, Mi-Jin
    Kim, Kwhanmien
    Kang, Won Ki
    Park, Keunchil
    Shim, Young Mog
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 77 - 84
  • [9] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
    Jeeyun Lee
    Young-Hyuck Im
    Eun Yoon Cho
    Yong Sang Hong
    Hyo Rak Lee
    Hyo Song Kim
    Mi-Jin Kim
    Kwhanmien Kim
    Won Ki Kang
    Keunchil Park
    Young Mog Shim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 77 - 84
  • [10] Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
    Su Jin Lee
    Sungmin Kim
    Moonjin Kim
    Jeeyun Lee
    Yeon Hee Park
    Young-Hyuck Im
    Se Hoon Park
    BMC Cancer, 15
12345